pmc logo image
Prediction of breast cancer sensitivity to neoadjuvant chemotherapy based on status of DNA damage repair proteins
Hideki Asakawa, Hirotaka Koizumi, Ayaka Koike, Makiko Takahashi, Wenwen Wu, Hirotaka Iwase, Mamoru Fukuda, Tomohiko Ohta
Breast Cancer Res. 2010; 12(2): R17. Published online 2010 March 5. doi: 10.1186/bcr2486
PMCID:
PMC2879561
Abstract Full Text PDF–4.8M Supplementary Material
 Is Cited by the Following 2 Articles in this Archive:
Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness
Esther H Lips, Nadja Laddach, Suvi P Savola, Marieke A Vollebergh, Anne MM Oonk, Alex LT Imholz, Lodewyk FA Wessels, Jelle Wesseling, Petra M Nederlof, Sjoerd Rodenhuis
Breast Cancer Res. 2011; 13(5): R107. Published online 2011 October 27. doi: 10.1186/bcr3049
PMCID:
PMC3262220
Abstract Full Text PDF–377K
The ups and downs of DNA repair biomarkers for PARP inhibitor therapies
XiaoZhe Wang, David T Weaver
Am J Cancer Res. 2011; 1(3): 301–327. Published online 2010 January 3.
PMCID:
PMC3180060
Abstract Full Text PDF–2.2M
You are here: NCBI > Literature > PubMed Central
Write to the Help Desk